TipRanks
KYORIN Pharmaceutical Co.,Ltd. (JP:4569)
:4569
Japanese Market
4569
KYORIN Pharmaceutical Co.,Ltd.
RESEARCH TOOLSreports
Want to see JP:4569 full AI Analyst Report?

KYORIN Pharmaceutical Co.,Ltd. (4569) Stock News & Sentiment

3 Followers
Kyorin to Divest Generic Drug Unit to New PCPI Platform, Sharpen Focus on New Drugs
Premium
Company Announcements
Kyorin to Divest Generic Drug Unit to New PCPI Platform, Sharpen Focus on New Drugs
11d ago
4569
KYORIN to Promote World’s First Cream Treatment for Allergic Conjunctivitis in Partnership with Santen
Premium
Company Announcements
KYORIN to Promote World’s First Cream Treatment for Allergic Conjunctivitis in Partnership with Santen
2M ago
4569
KYORIN Pharmaceutical Details Q1 Results and Pipeline Outlook for FY2027
Premium
Company Announcements
KYORIN Pharmaceutical Details Q1 Results and Pipeline Outlook for FY2027
2M ago
4569
KYORIN Pharmaceutical Warns of Profit Slump and Dividend Cut Despite Strong Balance Sheet
Premium
Company Announcements
KYORIN Pharmaceutical Warns of Profit Slump and Dividend Cut Despite Strong Balance Sheet
2M ago
4569
KYORIN, Santen Team Up to Expand Marketing of Novel Allergic Conjunctivitis Cream in Japan
Premium
Company Announcements
KYORIN, Santen Team Up to Expand Marketing of Novel Allergic Conjunctivitis Cream in Japan
3M ago
4569
KYORIN Pharmaceutical Keeps Annual Dividend Steady at ¥57 Per Share
Premium
Company Announcements
KYORIN Pharmaceutical Keeps Annual Dividend Steady at ¥57 Per Share
5M ago
4569
KYORIN Expands Performance-Linked Stock Compensation Plan to Corporate Officers
Premium
Company Announcements
KYORIN Expands Performance-Linked Stock Compensation Plan to Corporate Officers
5M ago
4569
More JP:4569 News >

4569 News on the Web

Kyorin to Divest Generic Drug Unit to New PCPI Platform, Sharpen Focus on New Drugs
TipRanks News
Bullish
KYORIN, Santen Team Up to Expand Marketing of Novel Allergic Conjunctivitis Cream in Japan
TipRanks News
Bullish
KYORIN Licenses BIODOL’s Novel Neuropathic Pain Drug for Key Asian Markets
TipRanks News
Bullish
KYORIN Secures Exclusive Japan Rights to Promote and Distribute J&J’s SIRTURO
TipRanks News
Neutral
Kyorin Pharma Overhauls Governance With New Mandate-Based Officer System
TipRanks News
Neutral
KYORIN Partners with Hinge Bio for SLE Drug Development in Japan
TipRanks News
Neutral

News Score - Last 7 Days

Not enough data to generate a sentiment score
Media Buzz
This Week0 articles
Weekly Average0.25 articles
News Sentiment
Currently, no data available
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is JP:4569’s Media Buzz Sentiment?
Currently, no data Available
What is JP:4569’s weekly average amount of articles?
In an average week, 0.25 articles about JP:4569 are published.
    What is JP:4569’s News Sentiment?
    Currently, no data Available
    Healthcare Stocks that are Trending in the News
    CMXHFCSL
    RZLTRezolute
    AMGNAmgen
    PMCUFPro Medicus Limited
    ABTAbbott Laboratories
    Showing the stocks with the most bullish news sentiment over the past week